Good morning :)
$
₹
Veeva Systems Inc Class A

Veeva Systems Inc Class A

VEEV

NYSE
Asset Logo

Veeva Systems Inc Class A

VEEV

NYSE
$310.080.17% (-0.55)
$
₹
$310.080.17% (-0.55)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Health Information Services

Large Cap

With a market cap of $49.1B the stock is ranked 330

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

50.36
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

6.68
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$6.02
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.18
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

29.35%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 29 analysts reports

Buy
20 analysts
Hold
8 analysts
Sell
1 analyst

Price Upside

-2.12%

Earnings Growth

+14.58%

Rev. Growth

+15.49%

See Detailed Forecast

Company Profile

Company Profile

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Doximity Inc
DOCS
Doximity Inc
P/E Ratio
38.35
38.35
1Y Return
45.81%
45.81%
Buy Reco %
38.09
38.09
Waystar Holding Corp. Common Stock
WAY
Waystar Holding Corp. Common Stock
P/E Ratio
40.66
40.66
1Y Return
21.41%
21.41%
Buy Reco %
91.30
91.30
Schrodinger Inc
SDGR
Schrodinger Inc
P/E Ratio
—
—
1Y Return
45.52%
45.52%
Buy Reco %
71.42
71.42
Inspire Medical Systems Inc
INSP
Inspire Medical Systems Inc
P/E Ratio
13.63
13.63
1Y Return
19.57%
19.57%
Buy Reco %
22.22
22.22
Certara Inc
CERT
Certara Inc
P/E Ratio
—
—
1Y Return
4.14%
4.14%
Buy Reco %
30.76
30.76
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies -2.12% growth, versus a trailing 3-year CAGR of 16.49%.

2026
Current$310.1Baseline
Analyst Target - 1 year
Target$303.52-2.12%

All values in $

202220232024202520262027$194.21$243.18$292.14Target-2.12%
2026
Current$310.1Baseline
Analyst Target - 1 year
Target$303.52-2.12%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 15.49% growth, versus a trailing 3-year CAGR of 14.03%.

2026
Current$3.19Baseline
Forecast for Jan 2027
High$3.72+16.65%
Average$3.69+15.49%
Low$3.68+15.17%

All values in $ Billion

2022202320242025202620271.852.152.362.743.19Low+15.17%Average+15.49%High+16.65%
2026
Current$3.19Baseline
Forecast for Jan 2027
High$3.72+16.65%
Average$3.69+15.49%
Low$3.68+15.17%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 14.58% growth, versus a trailing 3-year CAGR of 23.30%.

2026
Current$8.06Baseline
Forecast for Jan 2027
High$9.38+16.38%
Average$9.24+14.58%
Low$9.17+13.77%

All values in $

2022202320242025202620273.724.34.846.618.06Low+13.77%Average+14.58%High+16.38%
2026
Current$8.06Baseline
Forecast for Jan 2027
High$9.38+16.38%
Average$9.24+14.58%
Low$9.17+13.77%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

811.2
236.2
835.9
244.2
882.9
260.9
927.9
273.4
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue650.34676.18699.20720.88759.04789.08811.23835.95882.94927.96
Net Income161.66171.04185.80195.62228.19200.30236.20244.20260.93273.42
Net Profit Margin24.85%25.29%26.57%27.13%30.06%25.38%29.11%29.21%29.55%29.46%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealth Information Services

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Veeva Systems Inc Class A 50.366.681.18
Doximity Inc38.356.390.58
Waystar Holding Corp. Common Stock40.661.35-
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare VEEV with any stock or ETF
Compare VEEV with any stock or ETF
Comparing from
VEEV
DOCS
WAY
Loading...

Frequently asked questions

  1. Veeva Systems Inc Class A (VEEV) share price today is $310.08 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $313.59 and a day low of $305.54.

  2. Veeva Systems Inc Class A stock trades on NYSE under the ticker symbol VEEV.

  3. Veeva Systems Inc Class A's market capitalization is $49.09B as of November 6, 2026 at 2:29 AM IST.

  4. Veeva Systems Inc Class A's price-to-earnings (P/E) ratio is 50.36 as of November 5, 2026.

  5. Veeva Systems Inc Class A's price-to-book (P/B) ratio is 6.68 as of November 5, 2026.

  6. Yes, You can buy Veeva Systems Inc Class A shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Veeva Systems Inc Class A shares in three steps: 1. Search Veeva Systems Inc Class A on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Veeva Systems Inc Class A trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Veeva Systems Inc Class A (VEEV) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0322 shares at the current price of $310.08.

Loading...